However, the expression and polymorphisms of FoxP3 in patients with HT are lower and higher, respectively, than those observed in controls, which are often accompanied by decreased proportions of CD4+CD25+FoxP3+ cells 33, 48, 87, 88. The gene discussed is FOXP3; the disease is hematocrit.